Vanda Pharmaceuticals, Inc. (VNDA)
Healthcare: Biotechnology
Schedule 13D and 13G filings submitted since 09/30/2011
| Filing Company | Date of Filing |
Total Reported Shares Owned |
Shares Reported on 13F |
|
|---|---|---|---|---|
| SC 13G/A | WELLS FARGO & CO/MN | 06/10/2011 | 919,578 | 247,976 |
| SC 13G | RA CAPITAL MANAGEMENT, LLC | 08/12/2011 | 1,427,320 | 1,437,320 |
*Shares are split adjusted
